Page 121 - Biomedical Engineering and Design Handbook Volume 2, Applications

100 MEDICAL DEVICE DESIGN

Bernstein, A. D., J. C. Daubert, et al. (2002). “The revised NASPE/BPEG generic code for antibradycardia,
adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing
and Electrophysiology Group.” Pacing Clin Electrophysiol, 25(2):260–4.
Bernstein, A. D. and V. Parsonnet (1996a). “The NASPE/BPEG pacemaker-lead code (NBL code).” Pacing Clin
Electrophysiol, 19(11 Pt 1):1535–6.
Bernstein, A. D. and V. Parsonnet (1996b). “Survey of cardiac pacing and defibrillation in the United States in
1993.” Am J Cardiol, 78(2):187–96.
Bernstein, A. D. and V. Parsonnet (2001). “Survey of cardiac pacing and implanted defibrillator practice patterns
in the United States in 1997.” Pacing Clin Electrophysiol, 24(5):842–55.
Bertrand, O. F., R. Sipehia, et al. (1998). “Biocompatibility aspects of new stent technology.” J Am Coll, Cardiol,
32(3):562–71.
Besarab, A., J. Work, et al. (2006). “Clinical practice guidelines for vascular access.” Am J Kidney Dis, 48(l Suppl 1):
S176–276.
Biancari, F. and M. Lepantalo (1998). “Extra-anatomic bypass surgery for critical leg ischemia. A review.”
J Cardiovasc Surg (Torino), 39(3):295–301.
Bolooki, H. (1998a). Chapter 6: Balloon pump equipment. Clinical Application of the Intra-Aortic Balloon
Pump. H. Bolooki. Armonk, NY, U.S.A., Futura Pub. Co.:73–85.
Bolooki, H. (1998b). Chapter 7: Balloon pump consoles and catheters. Clinical Application of the Intra-Aortic
Balloon Pump. H. Bolooki. Armonk, NY, U.S.A., Futura Pub. Co.:87–107.
Bolooki, H. (1998c). Chapter 8: Physiology of balloon pumping. Clinical Application of the Intra-Aortic Balloon
Pump. H. Bolooki. Armonk, NY, U.S.A., Futura Pub. Co.:109–161.
Bonhoeffer, P., Y. Boudjemline, et al. (2000). “Percutaneous replacement of pulmonary valve in a right-
ventricle to pulmonary-artery prosthetic conduit with valve dysfunction.” Lancet, 356(9239):
1403–5.
Bonow, R. O., B. Carabello, et al. (1998). “Guidelines for the management of patients with valvular heart dis-
ease: executive summary. A report of the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).”
Circulation, 98(18):1949–84.
Bonow, R. O., B. A. Carabello, et al. (2006). “ACC/AHA 2006 guidelines for the management of patients with
valvular heart disease: a report of the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of
patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular
Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society
of Thoracic Surgeons.” J Am Coll Cardiol, 48(3):el-148.
Boriani, G., I. Diemberger, et al. (2007). “How, why, and when may atrial defibrillation find a specific role in
implantable devices? A clinical viewpoint.” Pacing Clin Electrophysiol, 30(3):422–33.
Borovetz, H. S., P. Litwak, et al. (1997) Membrane apparatus with enhanced mass transfer via active mixing.
U.S.A. Patent 6,106,776. April 11, 1997.
Brewster, D. C. (2000). Chapter 37: Prosthetic grafts. Vascular Surgery. R. B. Rutherford. Philadelphia, PA,
U.S.A., W. B. Saunders & Co.:559–584.
Bunt, T. J. (1983). “Synthetic vascular graft infections. I. Graft infections.” Surgery, 93(6):733–46.
Busch, T., H. Sirbu, et al. (1997). “Vascular complications related to intraaortic balloon counterpulsation: an
analysis of ten years experience.” Thorac Cardiovasc Surg, 45(2):55–9.
Butany, J. and M. J. Collins (2005). “Analysis of prosthetic cardiac devices: a guide for the practising patholo-
gist.” J Clin Pathol, 58(2):113–24.
Calligaro, K. D. and F. J. Veith (1991). “Diagnosis and management of infected prosthetic aortic grafts.” Surgery,
110(5):805–13.
Canaud, B., H. Leray-Moragues, et al. (2000). “Temporary vascular access for extracorporeal therapies.” Ther
Apher, 4(3):249–55.
Cazeau, S., C. Leclercq, et al. (2001). “Effects of multisite biventricular pacing in patients with heart failure and
intraventricular conduction delay.” N Engl J Med, 344(12):873–80.
Centers for Medicare and Medicaid Services. (2005, 12/14/2005). “Fistula first breakthrough.” Retrieved June 1, 2008,
from http://www.cms.hhs.gov/ESRDQualityImproveInit/04 FistulaFirstBreakthrough.asp.